F

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Associate Director - Business Development, Search & Evaluation

Corporate StrategyConfirmed live in the last 24 hours
Full-time

About the Job

Requirements

  • The candidate should have a strong scientific background paired with business acumen.
  • The candidate should have 1–3 years of post-degree experience combining scientific and business expertise.
  • The candidate should be able to build strong relationships within the biotech and pharmaceutical industries, leveraging existing contacts where applicable.
  • The candidate should be enthusiastic about networking, relationship building, and externally-facing activities.
  • The candidate should have an outgoing, motivated, and creative approach to business development.
  • The candidate should have curiosity and insight around the role of artificial intelligence in drug development, clinical trials, and business development.

Responsibilities

  • Support deal-by-deal opportunity assessment teams from asset identification through transaction close.
  • Collaborate with the business development team to identify target areas for outreach, focusing on strategic alignment with Formation Bio's goals.
  • Maximize activity and ensure high-quality support and diligence in strategic asset growth therapeutic areas and modalities.
  • Evaluate market potential and risk-based assessments of pipeline asset opportunities, assess upside, and engage the broader diligence team to ensure strategic fit.
  • Work cross-functionally with research and development, the technology platform, and commercial teams in an artificial-intelligence-native drug development company.

Desired Qualifications

  • Prior experience in biotech or pharmaceutical business development (search and evaluation), venture capital investing, or life sciences consulting is highly preferable.
  • A PhD in biological science or an MD with laboratory research experience is strongly preferred.

About the Company

Formation Bio

AI-driven platform accelerates clinical-stage drug development

Formation Bio uses an AI-driven platform to speed up drug development by focusing on clinical-stage assets. It acquires and advances these assets using flexible financing structures, aiming to shorten timelines and cut costs for bringing new drugs to market. The core product is the proprietary AI tools that help with drug selection, development planning, and improving overall efficiency, enabling partnerships and successful commercialization with pharmaceutical and biotech companies. Compared with competitors, Formation Bio combines a data-powered approach with adaptable financing and asset acquisition strategies to move assets forward quickly and cost-effectively. The goal is to make treatments more accessible and affordable by accelerating development and enabling faster, more predictable commercialization through AI-enhanced decision making and flexible funding options.

Company size
51-200
Company stage
Series D
Total funding
$530.3M
Headquarters
New York City, New York
Founded
2013

Recently Posted Jobs

Explore more opportunities at Formation Bio

See more jobs